Interferon messenger RNA content of human fibroblasts during induction, shutoff, and superinduction of interferon production by Sehgal, Pravinkumar B. et al.
Proc. Natl. Acad. Sci. USA
Vol. 74, No. 8, pp. 3409-3413, August 1977
Cell Biology
Interferon messenger RNA content of human fibroblasts during
induction, shutoff, and superinduction of interferon production
[human diploid fibroblast cells/poly(I)poly(C)/McAuslan-Tomkins translational repressor hypothesis/5,6-dichloro-l-l-D-
ribofuranosylbenzimidazole/Xenopus laevis oocytes]
PRAVINKUMAR B. SEHGAL, BERNHARD DOBBERSTEIN*, AND IGOR TAMM
The Rockefeller University, New York, New York 10021
Contributed by Igor Tamm, May 16, 1977
ABSTRACT Translation of injected mRNA in oocytes of
Xenopus laevis has been used as a highly sensitive and quanti-
tative assay for interferon mRNA. Injection into oocytes of
polyadenylylated RNA extracted from poly(I)poly(C)induced
human diploid fibroblasts (FS-4) leads to the synthesis of bio-
logically active human fibroblast interferon over a period of
24-32 hr. There is a linear relationship between the amount of
mRNA injected and the interferon yield obtained over a range
of 1-20 ng of injected RNA. Injection of 40-80 ng ofmRNA into
each of 15 oocytes, homogenized in 0.3 ml of incubation medi-
um, gave a titer of 128-256 interferon reference units/ml of
homogenate.
FS-4 cells at the peak of interferon production-i.e., ap-
proximately 2.5 hr after the beginning of induction with
poly(I)poly(C-gave mRNA that yielded 24-48 interferon ref-
erence units/ml in the oocyte assay (30 ng ofRNA injected per
oocyte). An equivalent amount ofmRNA from FS-4 cells in the
shutoff phase, approximately 6 hr after induction, gave <4 in-
terferon reference units/ml. In contrast, mRNA extracted from
FS-4 cells that had been induced and maintained in the presence
of 40 uM 5,6-dichloro-1-j-o-ribofuranosylbenzimidazole for 6
hr produced 64-128 interferon reference units/ml. Polyade-
nylylated RNA obtained from uninduced FS-4 cells did not lead
to detectable interferon synthesis (<4 interferon reference
units/ml). These data provide a direct verification of the hy-
pothesis that the shutoff of interferon production in FS-4 cells
involves a regulatory event leading to the posttranscriptional
inactivation or degradation of interferon mRNA. Because the
inactivating mechanism is sensitive to inhibition by 5,6-di-
chloro-1--D-ribofuranosylbenzimidazole, a selective inhibitor
of nuclear heterogeneous RNA and mRNA synthesis, it is likely
that synthesis of an RNA molecule is necessary for the shutoff
of interferon production.
Human fibroblast interferon is a glycoprotein with an apparent
molecular weight of 21,000 (1, 2) and is characterized by the
F antigenic determinant (3). Cultures of human diploid fi-
broblasts (FS-4 strain) can be induced to synthesize and secrete
interferon into the extracellular medium by exposure to poly-
(inosinic acid)-poly(cyticylic acid) [poly(I)'poly(C)] (4-8). Ex-
tensive studies with inhibitors of RNA or protein synthesis in-
dicate that the regulation of interferon production in
poly(I)-poly(C)-induced FS-4 cells is complex (7, 9-11). Fig.
1 presents a summary of the key events thought to underlie
poly(I)-poly(C)-induced interferon production in FS-4 cells,
as revealed through inhibitor studies (10).
Interferon production in FS-4 cells reaches detectable levels
approximately 1 hr after the beginning of induction, rises to a
peak by 2.5-3 hr, and is rapidly shut off by 6-8 hr (5, 10, 12).
Inhibitors of RNA or protein synthesis, applied before the
shutoff, prevent the shutoff and lead to a continuous production
of interferon for up to 4 days (7, 9, 10, 12, 13). As a result, there
occurs a paradoxical increase ("superinduction") of up to a
100-fold in the cumulative interferon yield (7, 9, 13-15). De-
tailed analyses of the kinetics of interferon production by
poly(I)-poly(C)-induced FS-4 cells have led to the suggestion
that the rate of interferon production in response to poly(I).
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poly(C) is determined by two processes (7, 16). The inducer
brings about the rapid synthesis of interferon mRNA, which
is largely complete by 3 hr after the beginning of induction (5,
13, 16, 17). Indirect evidence suggests that interferon mRNA
has a half-life of 12-15 hr at 370 in the presence of inhibitors
of RNA synthesis (12, 13).
Concurrently with the induction of the synthesis of interferon
mRNA, poly(I)-poly(C) is thought also to bring about the syn-
thesis of an RNA species, and possibly also of a protein species,
that is responsible for posttranscriptional repression of interferon
mRNA. This repressor mechanism is thought to be responsible
for the rapid shutoff of interferon production by 6-8 hr after
induction despite the intrinsic stability of interferon mRNA (7,
16, 18). It has been proposed that inhibitors of macromolecular
synthesis, given at appropriate times, interfere with the syn-
thesis of components of the shutoff mechanism and hence are
able to enhance interferon yield (5, 7, 9, 10, 12, 14, 15, 18, 19).
The molecules mediating the shutoff appear to be unstable and
to have an overall lifetime of only 3-4 hr (7, 16). Furthermore,
the shutoff mechanism appears to inactivate interferon mRNA
in an irreversible manner (7). It has been suggested that a
translational repressor of the kind hypothesized by McAuslan
(20) and by Tomkins (21-23) is responsible for the shutoff of
poly(I)-poly(C)-induced interferon production in human dip-
loid fibroblasts (7, 9, 14, 15).
It has been discovered recently that polyadenylylated RNA
extracted from interferon-producing human or mouse cells can
be translated in wheat-germ, mouse Ehrlich ascites, Krebs-II
ascites, and rabbit reticulocyte cell-free translation systems and
in the Xenopus laets* oocyte, with the production of biologi-
cally active and specific interferon (24-26).
We have used the X. Iaevts oocyte injection assay for inter-
feron mRNA (26, 27) to carry out a direct biochemical test of
the hypothesis that the shutoff of poly(I)-poly(C)-induced in-
terferon production in FS-4 cells involves the irreversible in-
activation of interferon mRNA. The results described in this
communication provide strong support for this hypothesis and
show that such inactivation can be prevented by 5,6-dichloro-
1-/3-D-ribofuranosylbenzimidazole (DRB), an inhibitor of RNA
synthesis (10, 12, 28, 29).
MATERIALS AND METHODS
Cell Cultures. A human diploid fibroblast strain (FS-4) (5,
30) has been used in all experiments (7, 19, 31). Interferon ti-
trations were carried out with a human cell strain trisomic for
chromosome 21 (GM258) (32) obtained from the Human Ge-
netic Mutant Cell Repository, Camden, NJ.
Abbreviations: poly(I)-poly(C), poly(inosinic acid)-poly(cytidylic acid);
DRB, 5,6-dichloro-1-f,-D-ribofuranosylbenzimidazole; Pi/NaCl,
phosphate-buffered saline.
* Present address: European Molecular Biology Laboratory, Postfach
10.2209, 69 Heidelberg, Germany.
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FIG. 1. Scheme of transcription of interferon mRNA and re-
pressor RNA-determinants of interferon synthesis in a culture of FS-4
cells induced with poly(I)-poly(C).
Interferon Induction and Titration. Interferon was induced
by exposing confluent FS-4 cultures, washed once with warm
phosphate-buffered saline [Pi/NaCl (ref. 33)], to a solution of
poly(I)-poly(C) (12.5 or 20 lg/ml, P-L Biochemicals, Inc.) in
Eagle's minimum essential medium for 1 hr at 37°. Interferon
was assayed by means of the semimicro method using GM258
cells (30, 34). Interferon titers are expressed in terms of the
69/19 reference standard. One reference unit/ml titrated at
2 units/ml in the assay we used.
Cell Fractionation and RNA Extraction. Cultures were
rinsed four times with ice-cold Pi/NaCl, and the cells were
scraped into cold Pi/NaCl and pelleted in a refrigerated cen-
trifuge (1000 rpm, 3 min). The cell pellet was either extracted
with phenol directly or the nuclear and cytoplasmic fractions
were isolated first and then extracted with phenol. For frac-
tionation, the cells were resuspended in one-third-strength re-
ticulocyte standard buffer (3.3mM NaCl/0.5 mM MgCI2/3.3
mM Tris-HCI, pH 7.4) for 10 min and the cells were broken in
a Dounce homogenizer. Nuclear and cytoplasmic fractions were
separated by centrifugation (2000 rpm, 3 min) and the nuclear
pellet was further washed with detergent (0.5% deoxycho-
late/1.0% Tween 40) before RNA extraction (35, 36). RNA
from the cytoplasmic fraction was phenol extracted at neutral
pH and room temperature whereas that from the nuclear
fraction and from whole cells was extracted at low pH (pH 5.1
in acetate buffer) at 650 by procedures described earlier (29,
37-39). Polyadenylylated RNA was isolated by poly(U)-
Sepharose chromatography (37-39).
Translation ofmRNA in Oocytes of X. laevis. Oocytes were
obtained by dissection of mature X. laevts females purchased
from Nasco (Fort Atkinson, WI). Oocytes were used within 2
days of dissection. Clusters of approximately five fully devel-
oped oocytes were microinjected with 100-150 nl per oocyte
of the appropriate RNA dissolved in distilled water or in in-
jection buffer (88mM NaCI/15 mM Tris-HCI, pH 7.6; ref. 40).
Ten to 15 oocytes were usually injected per variable. Five in-jected oocytes were incubated per 0.1 ml of sterile modified
Barth's medium (40) at room temperature (21-230). At the end
of the incubation, the oocytes were broken by means of a cap-
illary pipette in the same aliquot of medium that was used for
incubation. The homogenate was clarified by centrifugation
for 30 min at top speed in a Beckman Microfuge at 40 and two
50-Al aliquots of the clarified supernate were used to make up
a 2-fold dilution series to test for interferon in duplicate as-
says.
Cell-Free Translation of mRNA. This was carried out in the
wheat germ and HeLa cell systems by using previously de-
scribed procedures (24, 41, 42).
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FIG. 2. Time-course of synthesis of interferon in oocytes injected
with interferon mRNA. Cytoplasmic polyadenylylated RNA (@) (see
Table 1) was injected into 50 oocytes (80 ng of RNA per oocyte). An
equivalent amount of nuclear polyadenylylated RNA (U) (Table 1)
was also injected into 15 oocytes (40 ng of RNA per oocyte). Groups
of 10 injected oocytes were harvested at different times after injection
and the amount of interferon synthesized was determined.
Interferon Neutralization Test. Specific antisera directed
against human fibroblast interferon (anti-F antiserum) and
human leukocyte interferon (anti-Le antiserum) were a gift
from E. A. Havell, New York University School of Medicine,
New York, NY. Interferon neutralization by antiserum was
tested as described (3).
RESULTS
Cell-Free Translation of Interferon mRNA. Our initial
efforts were directed at establishing a reproducible cell-free
translation assay for interferon mRNA based on a bioassay (30,
34, 43) to detect interferon synthesis. Polyadenylylated total
cellular RNA as well as cytoplasmic and nuclear poly(A)-con-
taining RNA were obtained from gram quantities of FS-4 cells
that had been treated with poly(I)-poly(C) in the presence of
cycloheximide for 4 hr (25, 26). The mRNA preparations were
translated, together with control preparations of rabbit globin
and dog pancreas mRNAs, in the wheat-germ and HeLa
translation systems by using previously described procedures
(24-26, 41, 42). It was our uniform experience that mRNA
preparations from induced FS-4 cells stimulated incorporation
of radiocative amino acids in both systems to an extent com-
parable to the stimulation produced by rabbit globin and dog
pancreas mRNAs (approximately 25-fold in the wheat-germ
system and 7-fold in the HeLa system). Nevertheless, no in-
terferon activity was detectable in the translation products (<10
reference units/ml). Varying the concentration of spermine in
the translation system and adding a membrane fraction from
dog pancreas (44, 45) did not alter this result. Inasmuch as the
same cytoplasmic and nuclear RNA preparations were effi-
ciently translated into biologically active human fibroblast
interferon by X. laevis oocytes 6 months later (Figs. 2 and 3;
Table 1), it appears that synthesis of the interferon polypeptide
is not by itself sufficient to generate biologically active inter-
feron.
Translation of Interferon mRNA in Oocytes of X. laevis.
The same sample of polyadenylylated cytoplasmic mRNA
obtained from induced FS-4 cells that had been used in some
of the cell-free translation experiments was used to obtain data
presented in Table 1 and Figs. 2 and 3. Oocytes were injected
with mRNA and incubated for 48 hr. The clarified oocyte ho-
mogenates were tested for interferon activity. As can be seen
in Table 1, X. laevis oocytes synthesized biologically active
interferon in high yield after injection of mRNA obtained from
poly(I)-poly(C)-induced FS-4 cells. Interferon activity was
neutralized by antiserum against human fibroblast interferon
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FIG. 3. Relationship between the amount of interferon mRNA
injected per oocyte and the interferon yield. A serial 2-fold dilution
of the interferon mRNA stock (Table 1) was prepared in injection
buffer and 15 oocytes were injected with about 150 nl each of the
various RNA dilutions. Interferon synthesized by the end of 48 hr was
determined.
but not by that against human leukocyte interferon. The oocyte
supernate was inactive in the interferon assay in mouse L cells.
In separate experiments, we have observed that control unin-
jected or mock injected oocytes as well as oocytes injected with
mRNA from uninduced FS-4 cells do not yield detectable in-
terferon activity (see Fig. 4).
The time-course of synthesis of interferon in oocytes after
injection of cytoplasmic polyadenylylated mRNA is described
in Fig. 2. It can be seen that interferon was detectable within
6 hr of mRNA injection. Maximal interferon yields were ob-
tained after 24-48 hr of incubation. In additional experiments,
maximal yields were obtained around 32 hr after injection (data
not shown). Total cellular polyadenylylated RNA from induced
cells gave similar results (data not shown). An incubation period
of 48 hr was therefore chosen for subsequent experiments.
It is noteworthy that nuclear poly(A)-containing RNA, when
injected into oocytes, resulted in the synthesis of interferon to
a level approximately 15-20% of that obtained with cytoplasmic
RNA (Fig. 2). Appropriate control experiments (not shown)
indicated that these molecules did not represent cytoplasmic
contamination of the nuclear RNA preparation.
The dependence of interferon synthesis in oocytes on the
amount of mRNA injected is illustrated in Fig. 3. Detectable
interferon yields were obtained by injection of approximately
1 ng of RNA per oocyte. There was a linear increase in the in-
terferon yield with increasing amounts of injected RNA in the
range of 1.2-20 ng of RNA. A maximum titer of 192 reference
units/mi was obtained by injecting 80 ng of RNA per oocyte.
The leveling off of the dose-response curve above 20 ng may
be the result of injecting sufficient mRNA to saturate the
translational capacity of the oocytes. Alternatively, the leveling
off may be due to saturation of the posttranslational modifi-
cation machinery that may operate in the synthesis of biologi-
cally active interferon in oocytes (46). The reproducibility of
this assay is demonstrated by the observation that the same
mRNA preparation gave identical interferon yields in three
separate experiments (80 ng of RNA injected per oocyte, fol-
lowed by incubation for 48 hr, gave 192 reference units/ml in
experiments summarized in Table 1 and Figs. 2 and 3). Our
overall experience indicates that variation in the oocyte assay
is no greater than variation in the interferon titrations (a 2-fold
error). We have used the oocyte assay to measure the concen-
tration of biologically active interferon mRNA during different
stages of interferon production in FS-4 cells.
Synthesis and Inactivation of Interferon mRNA in Human
Cells. The extraction of polyadenylylated mRNA and its
translation in X. Iaevis oocytes, described in the preceding
Table 1. Synthesis of human fibroblast interferon in oocytes
Interferon titer,
Condition of interferon assay ref. units/ml
Human GM258 cells 192
Human GM258 cells + anti-F antiserum <8
Human GM258 cells + anti-Le antiserum 192
Mouse L cells <4*
Confluent FS-4 cells in 17 roller bottles (490 cm2 each; Corning)
were exposed to poly(I)*poly(C) (12.5 mg/ml in Eagle's minimum es-
sential medium) in the presence of cycloheximide (50 jg/ml) for 4 hr.
At the end of this period, the cultures were washed four times with
ice-cold Pi/NaCl and the cells were harvested by scraping. The cell
pellet (about 1 ml packed volume) was resuspended in one-third-
strength reticulocyte standard buffer and the cytoplasmic and de-
tergent-washed nuclear fractions were isolated. RNA in the two
fractions was obtained by phenol extraction, and poly(A)-containing
RNA was selected by poly(U)-Sepharose chromatography. Poly-
adenylylated RNA was dissolved in 100 gl of distilled water. Each of
30 oocytes was injected with approximately 80 ng of cytoplasmic
poly(A)-containing RNA (about 150 nl per oocyte) and the oocytes
were incubated for 48 hr in modified Barth's medium in a total volume
of 0.6 ml. The oocytes were then homogenized in the same medium
and aliquots of the clarified homogenate were assayed for interferon.
Homogenates from mock-infected oocytes did not contain detectable
amounts of interferon (also see Fig. 4). The sensitivity of the L cells
to mouse interferon and the specificity of the antisera were verified
in separate control assays.
* A dilution of 1:4 was tested.
section, was scaled down for smaller quantities of cells. Ten
150-mm petri-dish cultures provided enough cells (about 0.3
ml packed volume) to allow the isolation of sufficient quantities
of total cellular polyadenylylated RNA. Answers to two key
questions were sought. First, did the shutoff of interferon
production involve a loss of translatable interferon mRNA?
Second, what effect did superinducing regimens such as the
presence of DRB throughout the production period have on
interferon mRNA content?
Fig. 4 and Table 2 present a summary of the results obtained.
As reported earlier (see the introduction), poly(I)-poly(C)-
induced FS-4 cells showed a burst of interferon synthesis that
peaked at approximately 3 hr after induction and was shut off
by 6-8 hr (Fig. 4). In the presence of 40 ,uM DRB, the rate of
interferon production showed a distinct lag and then continued
at a high level for an extended period of time (up to 4 days) (12,
13). We determined the relative content of interferon mRNA
in uninduced cultures, in induced cultures near the peak of
production (2.5 hr), in induced cultures in the shutoff phase (6
hr), and in cultures induced and maintained in 40MgM DRB for
6 hr. It is clear from Fig. 4 and Table 2 that the shutoff of in-
terferon production was accompanied by a loss or inactivation
of translatable interferon mRNA in induced cells. A similar
result was obtained when polyadenylylated RNA from the
cytoplasmic fraction was tested for interferon mRNA activity.
The presence of DRB in the cultures prevented this loss or in-
activation (Fig. 4 and Table 2). The data in Table 2 show that
the low yield of interferon obtained in oocytes injected with
mRNA preparations from cultures in the shutoff phase was not
an experimental artifact because mRNA samples from unin-
duced cultures or from cultures in the shutoff phase did not
interfere with the translation of known amounts of interferon
mRNA.
Table 2 also shows that RNA from interferon-producing cells
that did not bind to poly(U)Sepharose had no interferon mRNA
activity. However, these flow-through RNA preparations did
interfere with the translation of added interferon mRNA,
presumably because of their high content of ribosomal RNA
and contaminating DNA. This result suggests that it may be
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FIG. 4. Correlation between interferon production and interferon
mRNA content of FS-4 cells during induction, shutoff, and superin-
duction. Ten 150-mm Falcon petri-dish cultures of confluent FS-4
cells were used for each analysis. The cultures were induced with
poly(I).poly(C) (20 Ag/ml) in 10 ml Eagle's minimum essential me-
dium for 1 hr starting at "0 hour." One batch of cultures did not re-
ceive poly(I).poly(C) whereas another batch received poly(I)-poly(C)
together with 40MgM DRB. The DRB-treated batch was maintained
in DRB throughout the experiment. Two of the induced cultures were
used to monitor the rate of interferon production by hourly medium
(10 ml) change; one culture was from the DRB-free batch (o) and the
other was treated with DRB (o). DRB-containing samples were di-
alyzed prior to the assay for interferon. At 2.5 hr, a batch of induced
(*) and a batch of uninduced (A) cultures were harvested, and total
cellular RNA was fractionated into polyadenylylated RNA and
flow-through RNA by using a poly(U)-Sepharose column. Another
batch of induced cultures (U) and the DRB-treated cultures (0) were
similarly harvested at 6 hr after induction. The polyadenylylated RNA
and the flow-through RNA were ethanol precipitated and dissolved
in 20 and 100 ,l, respectively, of injection buffer. Approximately 2 ,l
of each polyadenylylated RNA preparation was injected into 13-15
oocytes (30 ng of RNA per oocyte) and interferon synthesis was
monitored.
premature to conclude that the poly(A)-lacking fraction does
not contain any interferon mRNA (24-26).
DISCUSSION
In previous reports, we have systematically evaluated several
different hypotheses that might explain superinduction of
human interferon production (for reviews see refs. 10 and 11).
It has become apparent, on the basis of indirect experiments,
that the enhancement of interferon production in FS-4 cells by
inhibitors of RNA or protein synthesis is not related to an in-
hibition of intralysosomal protein degradation (19) or to an
inhibition of mRNA competition during the shutoff phase (7).
However, evidence has been obtained, by using inhibitors such
as DRB, to implicate a posttranscriptional regulatory event in
the shutoff of human interferon production, mediated by a
rapidly turning over RNA and possibly by protein (9, 11-13,
17, 18, 47). These data are generally consistent with the hy-
pothesis that the shutoff of poly(I)-poly(C)-induced interferon
synthesis in FS-4 cells is mediated by a translational repressor
of the McAuslan-Tomkins type (14, 15, 20-23). McAuslan (20)
and Tomkins and his colleagues (21-23) suggested the possi-
bility that translation of mrRNA in eukaryotic cells might be
regulated in a specific manner by rapidly turning over RNA
and protein molecules that serve to repress, inactivate, or de-
grade mRNA. In the present study, we have carried out a direct
biochemical test of this hypothesis in the interferon system.
We have demonstrated that interferon mRNA is rapidly
inactivated or degraded during the shutoff phase but is pro-
tected in the presence of DRB, a selective inhibitor of nuclear
heterogeneous RNA and mRNA synthesis (28, 29, 48). The fact
that interferon mRNA is inactivated during the shutoff phase
in FS-4 cells has also been observed by R. L. Cavalieri, E. A.
Table 2. Interferon mRNA activity ofRNA preparations
Interferon titer, ref.
units/ml
Flow-
Poly(A)+ through
Cell cultures used RNA RNA
Uninduced, 2.5 hr <4 <4
Induced, 2.5 hr 48 <4
Induced, 6 hr 4 <4
Induced, DRB-treated, 6 hr <4
Alone 128
+ Uninduced, 2.5 hr, poly(A)+ RNA 48 (64*)
+ Induced, 6 hr, poly(A)+ RNA 192 (64*)
Induced, cycloheximide-treated, 4 hr
Alone 384
+ Uninduced, 2.5 hr, flow-through <4 (192)
+ Induced, 6 hr, flow-through <4 (192)
RNA preparations described in this table came from the experi-
ments presented in Fig. 4 and Table 1. Approximately 30 ng of poly-
adenylylated RNA [poly(A)+ RNA] or 500 ng of flow-through RNA
was injected per oocyte. In carrying out the mixing controls, equal
volumes (2MO) of the appropriate samples were mixed and then in-jected into oocytes. Hence, interferon yields from injecting mixtures
would be half of those obtained by injecting interferon-mRNA-con-
taining samples alone. Expected titers are indicated in parentheses.
Interferon mRNA from induced, cycloheximide-treated cells was
cytoplasmic polyadenylylated RNA as described in Table 1.
* Deviations indicate experimental variation and are not significant,
as demonstrated by other experiments.
Havell, S. Pestka, and J. Vil6ek (personal communication) using
the oocyte assay. These results differ from those reported re-
cently by Raj and Pitha (49). The observation that interferon
mRNA is inactivated or degraded during the shutoff phase is
entirely consistent with the McAuslan-Tomkins repressor hy-
pothesis.
A proper interpretation of the data presented in this com-
munication requires that the bioassay for interferon correctly
measure the quantity of interferon protein synthesized. At the
present time, the validity of the bioassay cannot be rigorously
proven. Nevertheless, Fig. 3 shows that a linear relationship
exists between the amount of mRNA injected into oocytes and
the interferon yield obtained over the range of 1-20 ng of RNA
injected per oocyte. This realtionship (slope about 45°) suggests
that the synthesis of biologically active interferon in the oocyte
translation assay correctly reflects the amount of interferon
synthesized, at least over this range of injected mRNA.
We have confirmed that oocytes produce active interferon
that possesses the same species specificity and the same im-
munological characteristics as interferon synthesized by cells
from wihch the mRNA was extracted (26, 27). Furthermore,
it has been shown by other investigators that, when injected into
X. laevis oocytes, interferon mRNA obtained from FS-4 cells
brings about the synthesis of interferon which has an apparent
molecular weight of 21,000 (26, 27).
It is known that oocytes can correctly cleave, acetylate,
phosphorylate, and'hydroxylate polypeptides synthesized in
response to injected mRNA (40,50). In preliminary experiments
with rat growth hormone mRNA (P. M. Sussman, P. B. Sehgal,
and C. Bancroft, unpublished data), we have observed that X.
laevis oocytes accumulate the processed growth hormone
polypeptide and not pregrowth hormone (51). It appears that
X. laevis oocytes efficiently accomplish the posttranslational
modifications of the interferon molecule necessary to generate
biologically active interferon, at least over the linear portion
of the curve'presented in Fig. 3. Our failure to observe inter-
feron synthesis in cell-free translation systems, such as the
3412 Cell Biology: Sehgal et al.
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wheat-germ system, may reflect the inability of our ce11-free
systems to perform these modifications. i
The loss of translatable interferon mRNA (Fig. 4 and Table
2) from cells in the shutoff phase indicates that the shutoff of
interferon production is not due to simple displacement of in-
terferon mRNA from polysomes by competing cellular mRNA(52). It is apparent that interferon mRNA does not survive in
FS-4 cells in an untranslated but phenol-extractable state as has
been observed during the shutoff of vitellogenin synthesis in
avian liver after a primary stimulation with estrogen (53). The
data obtained in the interferon system are also quite different
from those reported by Killewich et al. (54). These investigators
showed that the concentration of the mRNA for superinducible
tryptophan 2,3-dioxygenase, measured in a Krebs ascites cell-
free translation system during superinduction of the enzyme
activity by actinomycin D, was identical to that in actinomycin
D-free controls. The interferon mRNA content of cells super-
induced with DRB is markedly higher than that of comparable
cultures 6 hr after induction. It appears very likely that the
regulation of human interferon production involves a McAus-
lan-Tomkins type translational repressor which inactivates or
degrades interferon mRNA.
Note Added in Proof. We have observed that the rate of interferon
production and the concentration of translatable interferon mRNA
in FS-4 cells induced and maintained in the presence of DRB decay
with virtually identical half-lives. Thus, continued interferon pro-
duction in DRB-treated cells can be entirely explained in terms of the
level of functional interferon mRNA.
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